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Abstract 
 
The Effects of Carbohydrate and Protein Supplementation on Signaling 
Pathways Regulating Protein Turnover and Muscle Mass Following 
Chronic Resistance Training  
 
Lu Huang, M.S. Kin 
The University of Texas at Austin, 2016 
 
Supervisor:  Roger P. Farrar 
 
Skeletal muscle is important for physical activity and regulation of metabolism. 
Increase or maintenance of muscle mass is pursued by different populations ranging from 
athletes to people suffering from severe muscular diseases causing muscle 
atrophy/wasting. In this study, four animal groups were generated: sedentary group (No 
supplements or exercise) (SED); resistance training (RE) and whey supplements (WP); 
RE and combo (Carbohydrate and whey) supplements (CP); RE and placebo (DI water) 
(PLA). Flexor hallucis longus (FHL) muscles were collected after 8 weeks of training. 
Expression of several key proteins controlling muscle mass and protein turnover were 
measured in order to compare how different combinations affect muscle growth. It was 
found that resistance training induced reductions in myostatin protein expression 
compared with sedentary controls (p<0.05) and that MuRF was elevated in the CP group 
compared with sedentary group (p<0.05). We conclude that resistance training may 
upregulate protein synthesis through suppressing myostatin and that resistance training 
may increase muscle protein breakdown.   
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 1 
INTRODUCTION 
 
                 Forty percent of body weight is comprised of skeletal muscle, 
containing 50-75% of all proteins in the human body ((Rasmussen & Phillips, 2003) 
Skeletal muscle is important for physical activity and regulation of metabolism. 
Therefore, an enhancement of muscle mass is thought to be positively correlated with 
increased muscle strength and power, while the loss of muscle mass and strength severely 
affects quality of life. Athletes in power and strength sports are pursuing muscle 
hypertrophy to improve their performance in competitions. Meanwhile, aging, wasting of 
muscle use and some diseases may also lead to the quest to promote muscle hypertrophy 
in order to combat the loss of muscle mass and strength. Skeletal muscle constantly 
undergoes protein turnover and muscle growth is achieved when protein synthesis (MPS) 
exceeds protein breakdown (MPB), resulting in net protein accretion. These processes 
can be regulated through nutritional interventions and mechanical stress (Rasmussen and 
Phillips, 2003). Sarcopenia is the gradual loss of muscle mass usually seen as someone 
ages. It has been demonstrated that regular exercise combined with dietary intervention is 
more successful in treating sarcopenia compared with pharmacological intervention 
(Borster, 2004). While the effectiveness of resistance training combined with 
supplementations to stimulate muscle hypertrophy has been long studied, networks of 
signaling pathways and regulatory molecules coordinating adaptive responses to exercise 
have just been uncovered recently by molecular biologists (Egan and Zierath, 2013). The 
topic has recently received greater focus as NIH has stated “we have long known that 
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exercise is good for you, but no one really knows why”. Achieving better health and 
specifically addressing the maintenance and enhancement of muscle mass has been 
recognized as an important topic for better daily living and sustaining functionality 
throughout the life span.. 
     Resistance exercise (RE) is an important stimulus for muscle growth. It has 
been observed that during the initial stage of resistance training, the majority of strength 
gains resulted from neural adaptations (Mulligan et al. 1996). As resistance training 
proceeds, muscle hypertrophy occurs. It has been speculated that four primary factors are 
accounting for muscle hypertrophy initiated by resistance exercise: mechanical tension, 
muscle damage and recovery time and appropriate nutrition (Schoenfeld, 2010).             
Resistance exercise elevates mechanical stress upon the muscle, disturbs the 
integrity of muscular tissue. The mechanical tension is transduced through downstream 
signaling pathway such as IGF-1/PI3K/Akt/mTOR to promote protein synthesis. It has 
been demonstrated that hypertrophy associated with mechanical contraction can also be 
achieved by activating mTOR through phosphatidic acid independent of IGF-1/PI3K 
pathway (Hornberger et al. 2006). Protein synthesis can be regulated through two 
signaling pathways, the IGF-1-Akt-mTOR pathway, acting as a positive regulator, and 
the myostatin pathway, acting as a negative regulator. Ruas and his colleagues have 
shown that PGC1-alpha 4 is a unique transcription co-factor modulating IGF-1 and 
myostatin. In concert these factors promote muscle hypertrophy by upregulating IGF-1 
while suppressing myostatin.  Resistance training has been demonstrated to increase 
expression of PGC1-alpha 4 and reduce expression of myostatin (Ruas et al. 2012). 
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However, more research is necessary to uncover the underlying mechanisms as to how 
PGC1-alpha 4 mediates muscle growth. Exercise training can also induce localized 
damage, stimulating inflammatory factors, and subsequent regenerative factors to 
generate a hypertrophic response through activation of satellite cells via upregulation of 
mechano growth factor (Hill and Goldspink 2003). There’re some weak points on the 
sarcomeres, which are vulnerable to lengthening, and may cause a shearing of myofibrils 
when subjected to repeated movements. This muscular trauma is associated with 
inflammatory response, in which macrophages and neutrophils migrate to the injury site 
and remove the debris. Subsequently, these macrophages undergo polarization from a 
pro-inflammatory state to a pro-regenerative state, releasing cytokines and growth factors 
that further mediate satellite cell activation and muscle growth (Toigo and Boutellier, 
2006; Vierck et al. 2000). Moreover, metabolic stress results from exercise that mainly 
relies on ATP/CP or anaerobic glycolysis is partially responsible for exercise-induced 
muscle hypertrophy, as these energy systems lead to the metabolite buildup such as 
lactate acid, hydrogen ion and others (Suga et al. 2009). The metabolic stress results in 
alterations in hormonal milieu and free-radical production, inducing increase in muscle 
mass (Gordon et al. 1994; Goto et al. 2005).  
              Nutrient availability is one of the principal determinants of skeletal 
muscle protein turnover. It has been shown that in the early stages of recovery from 
exercise, muscular protein breakdown (MPB) may exceed muscular protein synthesis 
(MPS) in the absence of nutritional intake (Biolo et al. 1997). Transfer and incorporation 
of amino acids captured from dietary protein sources into skeletal muscle proteins is how 
 4 
protein supplementation functions to demonstrate its anabolic effects (Atherton and 
Smith 2012). Since muscle protein is lost in fasted periods due to amino acid oxidation 
and gluconeogenesis, there’s a need to compensate for the loss (Wackerhage and Rennie, 
2006). Therefore, protein supplementation with resistance exercise potentiates muscle 
protein accretion by supplying the amino acids pool. It’s been shown that protein 
supplementation can also positively regulate mRNA translation initiation via activating 
the mTOR signaling pathway and that increase of protein synthesis in response to 
increased essential amino acids will be blocked upon inhibition of mTOR (Dickinson et 
al. 2011). With protein or amino acid (AA) feeding, there’s a transient but significant 
increase in the rate of MPS without much change in MPB, rendering a positive net 
protein balance (Biolo et al. 1997). Three most commonly consumed protein sources are 
soy, casein and whey. Whey is rich in leucine and can be digested relatively fast and 
induce a more transient but larger increase in MPS compared with casein (Tang et al. 
2009). It was also found that within 3h post-exercise, whey protein could stimulate the 
highest rise in MPS compared with the other two sources (Tang et al. 2009). Protein 
supplementation in conjunction with resistance training is also associated with increases 
in serum insulin and IGF-1, both of which are able to augment MPS (Ballard et al. 2005).  
Insulin and IGF-1 can act on the insulin receptors located on sarcolemma, stimulating the 
PI3K-Akt/mTOR signaling pathway, which, as aforementioned, can positively affect 
MPS (Bolster et al. 2004). Besides, leucine is known to positively affect the downstream 
factors of mTOR pathway, indicating that AA and insulin function synergistically to 
optimize anabolic response in skeletal muscle (Rasmussen et al. 2000). It’s noteworthy 
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that provision of protein alone (without carbohydrate) causes a rise in insulin secretion 
similar to a mixed meal (Artherton et al. 2010). Besides, there’s an elevation in MPS 
upon infusion of amino acids even when insulin is clamped with β-cell inhibitor 
(Greenhaff et al. 2008). However, it has been shown that insulin plays an important role 
in an anti-catabolic fashion, in which it can suppress MPB. Question remains as to if 
taking carbohydrate on top of protein is necessary in order to get optimal muscle growth. 
At rest, insulin, when infused along with AAs, can promote MPS and suppress MPB 
(Bennet et al 1990). Biolo also demonstrated that following resistance exercise (RE), 
insulin is able to attenuate MPB without much impact on MPS (Biolo et al.1999). It’s 
reasonable to speculate that carbohydrate ingestion may potentiate muscle growth by 
inducing insulin secretion. However, while insulin is able to increase MPS upon 
activation of mTOR pathway, when AA delivery are increased as a result of protein/AA 
supplementation, it seems that AA alone can induce secretion of insulin and even low 
levels of insulin are able to optimize the stimulation. Therefore, co-ingestion of 
protein/AA with carbohydrate may not be able to further stimulate MPS compared with 
sole ingestion of protein/AA as long as protein/AA is adequate. (Huang & Manning, 
2008)Koopman and his coworkers found that co-ingestion of carbohydrate with protein 
didn’t further augment postexercise MPS (Koopman et al. 2007), validating the 
aforementioned mechanism. However, there remain valid reasons to incorporate 
carbohydrates into protein/AA supplements following resistance exercise, to replenish 
glycogen depletion and to suppress MPB.  
 6 
               Thus, this study will investigate how different supplements combined 
with resistance training affect muscle hypertrophy and through what mechanisms. 
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LITERATURE REVIEW 
MYOGENIC PATHWAYS AND MUSCLE HYPERTROPHY 
   The maintenance of muscle mass is important, because both sedentary and 
active adults will lose 30-40% of their muscle mass by the age of 80, which will severely 
affect their quality of life due to loss of independence and increased risk of injury. 
Meanwhile, an increase in muscle mass is desired by athletes to improve their 
performance in various competitions. Since muscle mass is a balance of muscle protein 
synthesis and muscle protein breakdown, the development of appropriate strategies to 
accelerate MPS and reduce MPB to maintain or even increase muscle mass is of great 
clinical and athletic importance. However, in order to develop such strategies, we must 
first need to establish a comprehensive understanding of the molecular mechanisms that 
regulate muscle mass/protein turn over.  
Anabolic Pathways 
Akt/mTOR 
              In adult skeletal muscle, the Akt/mTOR signaling pathway is currently 
believed to act as the major pathway regulating skeletal muscle growth (McCarthy and 
Esser, 2010). In general, Akt is a molecular nodal point, served as both an effector of 
anabolic signaling and an inhibitor of catabolic signaling. Research over the past years 
have revealed that mammalian target of rapamycin complex 1(mTORC1), here referred 
to as mTOR, is a central component of a signaling network that controls muscle mass, 
which can be regulated by various factors, including growth hormones, nutrients and 
mechanical stimuli. The mTOR complex consists of the proteins mTOR, G protein beta-
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subunit-like protein, and regulatory protein Raptor (Huang & Manning, 2008). The 
mTOR protein is a Ser/Thr kinase that contains multiple domains including FKBP12-
rapamycin binding domain (FRB), which will exert inhibitory effects on mTOR signaling 
when bound to FKBP12-rapamycin complex. The Raptor protein is an adaptor protein, 
recruiting downstream substrates to bind with mTOR and get phosphorylated. IGF-1 is 
well characterized as one of the growth hormones that trigger muscle(Rommel et al., 
2001) hypertrophy through various mechanisms, including activating PI3K/PKB-Akt-
mTOR pathway, mediating proliferation and differentiation of satellite cells and 
enhancing the fusion of satellite cells with existing muscle fibers to maintain the nuclear 
domain. Upon mechanical loading, it is widely accepted that mechanical stimuli activate 
mTOR through IGF1-mediated mTOR pathway, since muscles produce more IGF-1 
through both paracrine and autocrine manner during mechanical stimulation (Rommel et 
al., 2001) and the subsequent constitutive activation of PI3K-PKB pathway induces 
mTOR activation. IGF-1 activates class I phosphoinositide -3 kinase (PI3K), which 
further phosphorylates protein kinase B (PKB) (Reiling & Sabatini, 2006). Activated 
PKB inhibits the activity of the tuberous sclerosis complex (TSC1/2) complex, which 
acts as a GTPase for a protein named homolougously enriched in brain (Rheb). Rheb is a 
molecule that interacts with mTOR, which activates mTOR kinase domain and promotes 
the activation of mTOR signaling when charged with GTP (Huang & Manning, 2008). 
However, recent reports have shown that IGF-1 may not be absolutely necessary for the 
induction of muscle hypertrophy and other upstream mediators activating mTOR 
signaling may be involved to dictate muscle hypertrophy. A study conducted by 
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Spagenburg et al. demonstrated that mechanical activation of mTOR and hypertrophic 
response were still preserved with a transgenic mouse model lacking a functional IGF-1 
receptor, providing evidence that other upstream substrates may be involved in this 
process (Spagenburg et al. 2008). It has also been found that mechanical activation of 
mTOR can be independent of IGF-1 and actually acts through phosphatidic acid (PA), 
which competes with FKBP12-rapamycin complex to bind to the FRB domain site on 
mTOR to confer the resistance to the inhibitory effects that ramapacin has on mTOR 
(Hornberger et al. 2006). Furthermore, work from the Hornberger laboratory extends 
these initial findings by reporting that eccentric contraction-induced activation of mTOR 
was independent of PI3K-Akt activity (O’Neil et al. 2009). Thus, both IGF-1 and PA can 
be upstream triggers of mTOR signaling.  
Once mTOR is activated by phosphorylation, it will further activate other 
downstream factors like 70 kDa ribosomal protein S6 kinase (70S6K), which is typically 
used as a read-out of mTOR signaling. Baar and Esser found that the magnitude of the 
increase in the phosphorylation of 70S6K was highly correlated with the hypertrophic 
gains of muscles subjected to resistance exercise (Baar & Esser, 1999). The p70S6K is 
thought to induce the phosphorylation of ribosomal protein S6 (rpS6), one of the 
components of the eukaryotic 40S ribosomal subunit (Jastrzebski et al. 2007). Upon 
phosphorylation, rpS6 can further dictate the translation of mRNAs involved in 
increasing protein synthesis.  
β-catenin/c-Myc signaling 
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              Mechanical stimuli regulate protein synthesis through changes in both 
translational efficiency and translational capacity, the former one of which consists three 
main steps: initiation, elongation and termination. The pathway mentioned above is 
revealed to be primarily involved in the stage of initiation(Kimball, Farrell, & Jefferson, 
2002). β-catenin/c-Myc signaling pathway is considered to affect translational capacity, 
an important factor determining MPS and defined as the total ribosomal content per unit 
tissue (McCarthy and Esser 2010). Studies have provided evidence, suggesting that β-
catenin/c-Myc signaling pathway operates independent of the mTOR pathway in 
regulating ribosomal biogenesis. Mechanical overload-induced muscle growth was 
completely prevented by the muscle specific inactivation of the β-catenin gene, indicating 
the necessity of β-catenin for muscle hypertrophy. 
Catabolic Pathways 
   Muscle mass regulation is a sum of MPS and MPB, the latter of which involves 
three principal proteolytic systems in skeletal muscle: the ubiquitin-proteasome system, 
the autophagy-lysosome system and the Ca2+-dependent calpains and caspases. The 
ubiquintin-proteasome system is required to mediate myofibrillar protein degradation 
upon changes in muscle activity such as mechanical loading or unloading. The 
proteasome complex can only recognize and remove proteins with ubiquitins attached to 
them. There are three types of ubiquitin ligases believed to be involved in this process: 
the uniquitin-activating enzyme (E1), conjugation enzymes (E2s), and specialized ligases 
(E3s). Different E2-E3 pairs will dictate different proteins to be degraded and is precisely 
regulated. Goldberg’s group made a major contribution to identify the specific ubiquitin 
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ligases involved in the loss of muscle mass by comparing gene expression in different 
models of muscle atrophy(Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001). The genes 
induced most among these diverse disease models were found to encode two crucial 
ubiquitin E3 ligases in the skeletal muscle, atrogin-1 (also known as muscle atrophy F-
box (MAFbx)) and muscle ring-finger protein 1(MuRF1). The substrates for atrogin-1 
seem to be involved in growth-related processes, such as MyoD, a key muscle 
transcription factor associated with satellite cell differentiation, while MuRF1 was 
reported to control muscle structural proteins, such as troponin I and myosin heavy chains 
(Kedar et al., 2004). Autophagy is considered as a non-selective degradation pathway 
compared to ubiquitin-proteasome system. Lysosomes are membrane-bound organelles 
that can degrade proteins delivered to them as autophagic cargo. The crucial role of 
autophagy-lysosome system in skeletal muscle is recognized by evidence showing that 
alterations in this process lead to several genetic muscle diseases. Too much autophagy 
impairs myofiber homeostasis, causing excessive removal of proteins that are needed to 
maintain the normal cellular activities. On the other hand, insufficient autophagy results 
in retention of damaged components, leading to muscle weakness. Ca2+-activated 
proteasomes like calpains were thought to be involved in the degradation of contractile 
proteins (Purintrapiban et al. 2003). Several signaling pathways have been recognized 
recently to play important roles in muscle protein degradation and will be discussed 
separately below.  
NFkB sinaling 
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                NFkB transcription factors can mediate the effect of inflammatory 
cytokines such as tumor necrosis factor-alpha (TNFa) on muscle wasting ((Kang, 
Goodman, Hornberger, & Ji, 2015). When inactivated, NFkB is sequestered in the 
cytoplasm by inhibitory factors IkB. The IkB kinase (IKKb) complex phosphorylates IkB 
in response to TNFa, leading to IkB’s degradation, which initiates the translocation of 
NFkB to induce NFkB-mediated gene transcription like MuRF1 (Peterson, Bakkar, & 
Guttridge, 2011) Numerous studies have clearly shown the role NF-κB signaling plays in 
muscle atrophy. By introducing the dominant-negative inhibitor of κBα to inhibit the 
activity of NF-κB, Andrew Judge and coworkers prevented muscle fiber atrophy with 
contractile claudication in patients with peripheral arterial disease (PAD) (Hain, Dodd, & 
Judge, 2011). Furthermore, the Judge laboratory has reported that heat shock protein 70 
(Hsp70) and Hsp27 can prevent the loss in fiber cross sectional area (CSA) with 
immobilization and inhibit NF- κB activation (Senf et al. 2008; Dodd et al. 2009). 
Akt/FOXO3A signaling  
                MAFbx and MuRF1 are muscle-specific E3 ubiquitin ligase genes, 
which are thought to be central components of the ubiquitin/proteasome system in 
skeletal muscle. FOXO3A transcription factors can initiate muscle atrophy by activating 
MAFbx and MuRF1. FOXO3A is trapped in the cytoplasm when inactivated upon 
phosphorylation by Akt. However, once dephosphorylated, FOXO3A can enter the 
nucleus and induce the expression of atrogin and MuRF1, causing muscle atrophy. As 
mentioned above, IGF1 can elevate MPS by activating PI3K-Akt-mTOR-70S6K-rpS6 
pathway. Akt can control both protein synthesis, via mTOR, and protein degradation, via 
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FOXO3A. Several studies demonstrated that upregulation of atrogin and MuRF1 was 
blocked by Akt through exporting FOXO3A from the nucleus to the cytoplasm (citations, 
Lee et al, 2004). FOXO has also been found to interact with PGC-1alpha, a critical 
coactivator for mitochondrial biogenesis. Kang et al. revealed that overexpression of 
PGC-1alpha via transfection ameliorated mitochondrial deterioration and accelerated 
muscle mass recovery during the remobilization period following 14 weeks of 
immobilization in mice, with concomitant reduction of active FOXO3A, atrogin and 
MuRF1 (Kang et al. 2015).   
Myostatin Signaling 
    Myostatin is a member of TGFbeta family, predominantly expressed and 
secreted by skeletal muscle, functioning as a negative regulator for muscle growth. 
Mutations of the myostatin gene have led to excessive muscle growth observed in mice, 
sheep and cattle. It was demonstrated by recent studies that myostatin regulates muscle 
mass through two transcription factors, Smad2/Smad3. Interaction with Activin A allows 
myostatin to bind to and activate a heterodimeric receptor complex with kinase activity, 
comprising a type II receptor, activin receptor 2 (ActRIIB) and activin type I receptor, 
activin receptor-like kinase 4 and 5 (ALK4/5). Activation of activin type I receptor leads 
to the phosphorylation of Smad2/3, of which phosphorylated forms result in the 
formation of a heterodimeric complex with the common mediator Smad4 (Rodriguez et 
al., 2014; Schiaffino, Dyar, Ciciliot, Blaauw, & Sandri, 2013). However, the 
transcriptional targets of the heterodimeric complex have still been under investigation to 
uncover the inhibitory effects of myostatin on mucle growth.  
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A series of studies have suggested an interaction between myostatin signaling and 
Akt/mTOR signaling in regulating muscle mass (Sartori et al. 2009; Amirouche et al. 
2009). Activation of TGF-β through myostatin treatment has been shown to be associated 
with decreased activation of Akt as well as other components of Akt/mTOR signaling 
such as ribosomal protein S6, p70S6K (Trendlenberg et al. 2009). Inhibition of myostatin 
resulted in muscle hypertrophy dependent of mTOR signaling and independent of 
MuRF1 (Sartori et al. 2009). It seems that there’s some degree of crosstalk between 
Akt/mTOR and TGF- β pathways. However, other studies have revealed that myostatin 
activates FOXO1, leading to increased expression of atrogin in muscle cell cultures 
(McFarlane et al., 2006). Besides, myostatin expression is found to be under the 
regulation of FOXO1, which further supports the idea that myostatin pathway interacts 
with Akt/FOXO signaling (Allen & Unterman, 2007). 
MUSCLE ADAPTATION TO CHRONIC RESISTANCE TRAINING  
Muscle adaptation and protein turnover in response to resistance training 
               In humans, provided sufficient exercise intensity, acute increases in the 
rates of MPS and MPB will occur (Phillips et al. 1997). A single bout of resistance 
exercise can upregulate gene expression of several factors associated with muscle growth, 
indicating that muscle hypertrophy occurring with frequent bouts of resistance exercise 
can be partially explained by translational mechanisms (Willoughby and Nelson 2002). 
Animal studies can provide important information in terms of unraveling complicated 
cellular and molecular mechanisms. Therefore, mechanisms explaining muscle 
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hypertrophy through resistance training, different training modes as well as some animal 
models developed to mimic resistance training will be briefly reviewed below. 
Mechanisms of Resistance Exercise-Induced Muscle Hypertrophy 
    Chronic resistance training can primarily lead to muscle hypertrophy, an 
increase in muscle cross-sectional area (CSA). Increased MPS allows for expansion of 
myonuclear domain, which is the area governed by a single muscle nucleus. However, 
it’s considered that a ceiling exists for myonuclear domain and further increase in muscle 
mass requires the infusion of new nuclei to the muscle fiber to provide sufficient 
cytoplasmic capacity for protein expansion to occur, which suggests activation of satellite 
cells. Normally, satellite cells are quiescent and reside between basal lamina and 
sarcolemma. However, these myogenic stem cells can be activated and will proliferate, 
differentiate and fuse with existing cells or among themselves to create new myofibers 
during muscle regeneration or when there is a sufficient mechanical stimulus imposed on 
muscle fibers (Vierck et al. 2000). Therefore, hypertrophy could conceivably result from 
either an increase in the number of domains or an increase in the size of existing domains 
(Edgerton and Roy, 1991). The former concept has been strongly supported by research 
to date. Irradiation of satellite cells preceding TA muscle ablation has been demonstrated 
to block the hypertrophy of EDL muscle (Rosenblatt et al. 1994). Therefore, satellite cells 
may serve as the pool of a myonuclei to support muscle growth. Besides, satellite cells 
co-express myogenic regulatory factors like Myf5, MyoD, which are thought to play 
distinct roles in myogenesis (Sabourin and Rudnicki 2000). However, satellite cells will 
only be activated when the myonuclear domain reaches a critical size, below which 
accumulation of protein seems to be the sole factor accounting for muscle hypertrophy. 
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    The fact that MPS exceeds MPB following acute resistance exercise is well 
documented in both animals and humans, and these acute anabolic effects are believed to 
responsible for muscle growth over time during a longer training period. However, 
chronic resistance exercise (RE) training appears to attenuate the acute RE induced MPS . 
This can be partially explained by the adaptive muscle not stressed efficiently by the 
same absolute workload. Another reason accounting for this phenomenon is that training 
may shift the diurnal pattern of MPS. The latter explanation was supported by a study 
conducted by Gasier et al, where they found no significant difference in the acute rates of 
MPS (16h) between trained rats and sedentary controls, while the cumulative fractional 
rates of MPS (36h) did appear to be higher in the plantaris of trained rats cmpared to 
sedentary controls. This suggests that trained individuals may have a more rapid and 
stronger increase in the rate of protein synthesis. As mentioned above, the molecular 
mechanisms behind the elevation of MPS is the activation of mTOR, which can be either 
achieved by phosphorylation of Akt or binding with PA. Recent studies have revealed 
that a novel form of PGC-1alpha (PGC-1alpha4), which results from alternative splicing 
of the primary transcript, is also involved in muscle growth. It was shown that myotubes 
transduced with PGC-1alpha4 with adenovirus stimulated IGF-1 expression and 
suppressed myostatin expression, resulting in a 2-fold increase of protein/DNA compared 
with normal myotubes. In a hindlimb suspension model, they found that the expression of 
PGC-1alpha 4 decreased during the unloading phase and increased after reloading with a 
concomitant increase in the expression of IGF-1 and reduction of myostatin. Myotube 
growth induced by treatment with clenbuterol was blunted by PGC-1lapha4 knockdown 
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(Ruas et al. 2012). All of the evidence suggests a crucial role PGC-1alpha4 plays in 
regulating muscle mass  
Resistance Training Modes 
Resistance training has been well documented as a stimulus for muscle growth. 
However, it’s still controversial as to which exercise program is the best to trigger muscle 
hypertrophy. It has been proposed that reaching contractile failure is required for optimal 
muscle growth regardless of training loads (Morton et al. 2015). This contradicts the 
training protocol pointing out that relatively high training loads are better compared with 
low training loads to induce muscle growth (Campos et al. 2002). It has been suggested 
that as long as muscle fatigue exists, some motor units will drop out, requiring new motor 
unit activation and recruitment of other muscle fibers, which can probably result in a 
similar degree of muscle growth in either low- or high- resistance training (RE), 
considering comparable motor units being activated till contractile failure (Morton et al. 
2015). However, further studies are needed to compare the two different exercise 
approaches and find out the “best” way to optimize muscle hypertrophy.  
Animal Models 
Several animal models have been established to mimic human resistance training. 
Rats were stimulated to perform human squats. Squat training was composed of high-
intensity, short duration and graded overload exercise, which is very similar to the 
progressive overload exercise fashion that human goes through. 12 weeks of training 
resulted in fiber hypertrophy in the squat group compared with control, indicating that 
squat protocol is a good surrogate of RE for animals to induce muscle hypertrophy 
(Tamaki et al. 1992).  However, changes in muscle mass was only observed when 
 18 
expressed as a ratio of muscle weight to body weight, there was no absolute gains in 
muscle mass. Therefore, another animal model was developed, i.e. ladder climbing, to 
mimic the training parameters and adaptations observed in human progressive RE. After 
8 weeks of RE, it was shown that there was a 23% absolute increase in flexor halluces 
longus (FHL) muscle mass, with a daily accretion of about 0.3% (Hornberger and Farrar 
2004).  
NUTRIONAL INTERVENTION ON RESISTANCE TRAINING 
Protein supplementation on muscle protein turnover 
       High intensity of resistance training can cause a weaker training response and 
a prolonged recovery period with insufficient nutrient supplementation. It has been 
shown that in the early stages of muscle recovery from resistance exercise, MPB may 
exceed MPS in the absence of nutritional intake (Biolo et al. 1997). However, protein 
supplementation can favor MPS and augment protein accretion. Protein can increase the 
availability of amino acid for the muscle, thereby providing sufficient substrate for MPS 
(Bohé, Low, Wolfe, & Rennie, 2001). A meta-analysis performed by Cermak et al. 
summarized that the dietary protein supplementation increased fat free mass and strength 
gains compared with a placebo after prolonged resistance exercise training (Cermak et al. 
2012). It has also been shown that 10 weeks of resistance training in conjunction with 
either whey protein supplementation or dextrose placebo resulted in upregulation of 
markers indicative of MPS and subsequent improvements in muscle performance with 
protein supplementation being more effective than carbohydrate (Willoughby et al. 
2007). Another study conducted by Stine et al. also demonstrated that whey protein plus 
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carbohydrate on top of RE augmented muscle hypertrophy compared to isocaloric 
carbohydrate supplementation only (Rahbek et al., 2014). While they observed elevated 
phosphorylation of mediators involved in MPS, such as mTOR, Akt and 70S6k during 
acute RE, they failed to detect any changes in the total protein levels of Akt-mTOR 
pathway proteins following prolonged intervention, which suggests that these anabolic 
signaling proteins promote MPS mainly through acute phosphorylation. Leucine has been 
found to cause a high insulin response and believed to interact with intracellular sensors 
that activate mTOR (Dibble & Manning, 2013). It is believed that amino acids regulate 
mTOR through a different mechanism other than the class I PI3K-PKB pathway. 
However, it was also observed that activation of mTOR by nutrients was blocked when 
introducing the PI3K inhibitor wortmannin, suggesting that PI3K is required for this 
event. This led to the finding of a wormannin-sensitive class III PI3K named Vps34, 
which is now thought to be involved in AA-induced mTOR activation. The most widely 
accepted mechanism of AA-induced activation of mTOR involves the translocation of 
mTOR to lysosomal membranes, where both Rag GTPases and Rheb reside (Sancak et al. 
2010). Protein supplementation in conjunction with resistance training is also associated 
with increases in serum insulin and IGF-1, both of which are able to augment MPS 
(Ballard et al. 2005). Insulin and IGF-1 can act on the insulin receptors located on 
sarcolemma, stimulating the PI3K-Akt/mTOR signaling pathway, which, as 
aforementioned, can positively affect MPS (Bolster et al. 2004).  
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Caborhydrate supplementation on muscle protein turnover 
      The most acceptable mechanism for carbohydrate supplementation induced 
elevated MPS is via its positive effects on insulin release. At rest, insulin, when infused 
along with AAs, can promote MPS and suppress MPB (Bennet et al 1990). Other study 
found that following RE, insulin is able to attenuate MPB without much impact on MPS 
(Biolo et al.1999). While insulin is able to increase MPS upon activation of mTOR 
pathway, when AA delivery are increased as a result of protein/AA supplementation, it 
seems that AA alone can induce secretion of insulin and even low levels of insulin are 
able to optimize the stimulation. Therefore, co-ingestion of protein/AA with carbohydrate 
may not be able to further stimulate MPS compared with sole ingestion of protein/AA as 
long as protein/AA is adequate (Robert et al. 2015). Koopman and his coworkers found 
that co-ingestion of carbohydrate with protein didn’t further augment postexercise MPS 
(Koopman et al. 2007), validating the aforementioned mechanism. However, a study 
conducted by Bird et al. has revealed that carbohydrate (CHO) and essential amino acids 
(EAA) supplementation augments the anabolic response and hypertrophic gains 
compared to CHO, EAA or placebo group presumably by attenuating the post-exercise 
rise in protein degradation (Bird et al. 2006). Elevated cortisol levels post exercise 
confirms that catabolic events may predominate in the early stage post-exercise recovery 
from RE. Reduction of insulin levels will impede MPS, because insulin is one of the 
growth factors that can dictate MPS through activating mTOR signaling pathway. It was 
demonstrated that CHO+EAA supplementation potentiated the stimulation of MPS 
induced by ingestion of EAA alone in the presence of acute hypercortisolemia. EAA and 
CHO supplementation can increase the AA availability and insulin release, which 
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suppresses exercise-induced cortisol secretion, and therefore can possibly optimize 
muscle growth by enhancing MPS and suppressing MPB. However, as the results from 
various studies are controversial, there still remains a big gap as whether and how 
addition of CHO to protein supplementation can augment protein accretion during a long 
term period of RE. 
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SIGNIFICANCE 
   Comprising 40-50% of the total body mass, skeletal muscles are not only 
motors that drive locomotion, but they also play critical roles in breathing and whole 
body metabolism. Therefore, loss of muscle mass and strength with aging or disease 
severely affects quality of life. Both sedentary and active adults will lose 30-40% of their 
muscle mass by the age of 80, leading to their loss of independence, increased risk of 
morbidity and mortality, as well as an estimated $18.5 billion in annual healthcare costs 
in the United States. On the other hand, Athletes in power and strength sports are 
pursuing muscle hypertrophy to improve their performance in competitions. Thus, the 
development of appropriate strategies or therapies to restore, maintain and even increase 
muscle mass is of great importance both clinically and fiscally. Sarcopenia is the gradual 
loss of muscle mass usually seen as someone ages. It has been demonstrated that regular 
exercise combined with dietary intervention is more successful in treating sarcopenia 
compared with pharmacological intervention (Borst 2004).  
Acute RE elevated both MPS and MPB. Protein supplementation may increase 
MPS with minor effect on MPB. Recent research has suggested that addition of CHO to 
protein supplementation may potentiate muscle mass increase by inhibiting MPB via 
suppressing cortisol levels. However, the studies yielded controversial results in terms of 
the additive effects that CHO has on MPS. While the effectiveness of resistance training 
combined with supplementations to stimulate muscle hypertrophy is long known, 
networks of signaling pathways and regulatory molecules coordinating adaptive 
responses to exercise have just been uncovered recently by molecular biologists (Egan 
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and Zierath, 2013) and is still being largely investigated. Therefore, the goal of this study 
was to develop more effective ways to optimize muscle hypertrophy and understand the 
underlying mechanisms to shed some light upon possible therapeutic targets to promote 
increase in muscle mass.  
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METHODS 
ANIMAL  
                 A total of 31 male Sprague-Dawley rats were obtained at 
approximately 2 months of age from Charles River (Wilmington, MA). The rats were 
housed individually in their cages in order to monitor their diets and were maintained on 
a 12-hour light/dark cycle with the light phase from 8:pm to 8:am. Rats were provided 
standard lab chow and allowed ad libitum access to water. All experimental procedures 
were approved and conform the guidelines set by the Institutional Animal Care and Use 
Committee (IACUC) of the University of Texas at Austin. 
EXERCISE FAMILIARIZATION  
                       Following 1 week of acclimation to their new environment, rats 
underwent three repeated sessions of ladder climbing separated by 1 day between each 
session to get familiarized with the exercise protocol. During the familiarization period, 
rats carried no weights and climbed a ladder 1 m in height on an incline of 85° with 2 cm 
grid steps. Rats then completed three practice sessions of climbing separated by 1 day 
between each session with 50, 60, and 70 % of their body mass attached to their tails, 
respectively. The weight was attached at the base of the tail with foam tape (3 M Conan) 
and a Velcro strap. Rats were encouraged to climb by lightly tapping their tails with a 
bottlebrush. 
EXPERIMENTAL PROTOCOL 
                       During the experimental procedure, rats began high-intensity 
progressive resistance training according to Hornberger and Farrar (Hornberger and 
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Farrar, 2004). Following a 3-hour fast, rats were trained to climb the ladder once every 
three days for 8 weeks. Each training session consisted of 4-9 climbs requiring 8-12 
dynamic movements per climb. Based on the performance, the weight carried during each 
session was progressively increased.  
        Rats began climbing with carrying a weight equal to 75 % of their body mass 
attached at the base of the tail. There was a 2-min rest period between each climb. Upon 
successful completion of this load, an additional 30 g weight was added to the load 
apparatus. This procedure successively repeated until a load was reached with which 
prevented the rat from climbing the entire length of the ladder. The highest load 
successfully carried during the initial training session was considered as the rat’s 
maximal carrying capacity for that training session. Subsequent training sessions 
consisted of 4-9 ladder climbs. During the subsequent first 4 ladder climbs, the rats 
carried 50%, 75%, 90% and 100% of their previous maximal carrying capacity, 
respectively. Then an additional 30g load was progressively added until the rat’s new 
maximal carrying capacity was achieved. This training regimen was repeated once every 
3 days for 8 weeks, a total of 20 training sessions. Food consumed was be recorded every 
day. 
When every training session was completed, whey hydrolysate (WP = 0.5g/kg), 
carbohydrate plus whey (CP: whey=0.5g/kg, CHO=1.2g/kg) or placebo (8 ml/kg DI 
water) was given immediately post resistance exercise by intubation. Following 
intubation, lab chow was removed from cages for three hours and rats were allowed 
access to water ad libium. A total of seven rats were used as sedentary controls and 
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received an intubation of DI water (8 ml/kg) at the same time when rats from other 
groups were gavaged.  
      Rats in each treatment group were subdivided by time of euthanasia, which 
occurred within 24 hours post intubation (n = 7-8 per group). Rats were anesthetized with 
an intraperitoneal injection of sodium pentobarbital, (75 mg/kg of body weight) during 
which the flexor hallucis longus (FHL) were excised, freeze clamped in liquid nitrogen, 
and stored at − 80 °C for later analysis by Wendy Wang. Rats were then euthanized by 
cardiac injection of sodium pentobarbital (65 mg/kg of body weight). 
WESTERN BLOT ANALYSIS 
   The frozen muscle samples weighing ~100 mg were homogenized in ice-cold 
homogenization buffer [50 mM HEPES (pH 7.6), 150mM NaCl, 1% Triton-X 100, 
20mM beta-glycerol phosphate, 10mM NaF, 100 1 mM Na3VO4, 50 mM 
glycerophosphate, 10ng/ml each of leupeptin and aprotinin, 1 mM 
phenylmethanesulphonyl fluoride (PMSF), and 1:100 dilutions of phosphate inhibitor 
cocktails 1&2 (Sigma-Aldrich).] at a 1:15 dilution of wet weight muscle. The resulting 
homogenates was centrifuged at 12,000g for 30 min at 4 °C, and the supernatants were 
taken for measurement of total protein concentration determined as described by 
Bradford (74, David’s dissertation). All muscle homogenate aliquots were then be stored 
at −80 °C until analysis. Samples were boiled in 4X Laemmli’s sample buffer at a ratio of 
3:1 at 95 °C for 10 min in order to denature muscle, and equal amounts of total protein 
were loaded into each well of a 5% stacking/12.5%-15% separating polyacrylamide gel. 
Gels were run at constant current of 50mA for about 70 min until necessary protein 
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separation was achieved (Bio-Rad Laboratories, Hercules, CA.). The resolved proteins 
were then electrically transferred onto a PVDF membrane (Millipore) using a semi-dry 
transfer unit (Bio-Rad Laboratories, Hercules, CA) at 300mA for 45 min. Ponceau S. (0.1 
% in 0.5 % acetic acid) was used to verify the completeness of the transfer. The 
membranes were then washed in Tris-buffered saline (TBS) with 0.06 % Tween20 
(TTBS) to remove the Ponceau S staining, and then the membranes were blocked with 
5% skim milk in 0.06%TTBS (blocking buffer) for 1 h at room temperature (RT). The 
membranes were then incubated with the appropriate primary antibody overnight at 4 °C, 
usually in 1:1000 dilutions of primary antibody in either 1% skim milk-TBST or 5% 
BSA-TBST. The targeted proteins are PGC1-alpha4/1, myostatin, Murf, Atrogin, Foxo3a 
and phosphorylated Foxo3a. Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was 
used as an internal loading control. Most of the antibodies were purchased from Cell 
Signaling Technology (Cell Signaling Technology, Beverly, MA), except that the 
primary antibody for Gapdh was purchased from Santa Cruz and the primary antibody for 
Foxo3a was purchased from abcam. Following overnight primary antibody probing, all 
membranes were washed 5 min, three times with TTBS. Then, the membranes were 
incubated with a dilution of 1:2000 HRP-conjugated secondary anti-rabbit, anti-mouse or 
anti-goat IgG (Pierce) in 1% skim milk-TBST for 1 hour, depending on the host of the 
primary antibodies. After three additional 5-min washes, the membranes were visualized 
by enhanced chemi-luminescence (ECL) in accordance with the manufacturer’s 
instructions (Perkin Elmer, Boston, MA). All western blots were performed in duplicate 
for each muscle sample to ensure reproducibility. Images were captured using a charge-
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coupled device camera in a Chemi- Doc system (Bio-Rad, Hercules, CA). Intensity of 
each band was quantified with Image Lab analysis software (Bio-Rad). Following ECL 
detection of phosphor-proteins, membranes were stripped and re-probed for total protein 
or internal controls. 
STATISTICAL ANALYSIS 
                All values are expressed as mean ± SEM. A one-way ANOVA was 
used for the western blot results, and Fisher’s LSD post hoc test was performed to 
compare mean differences among treatments. Differences with p-values < or = 0.05 were 
considered statistically significant. All statistical analyses were performed using IBM 
SPSS Statistics v19.0 software (IBM Corporation, Armonk). 
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RESULTS 
    Expression of proteins involved in the regulation of muscle mass and protein 
degradation was investigated using western blot. PGC-1alpha isoform 1 and 4 levels are 
not different among groups. However, there is a trend of decline in PGC-1alpha1 and 
increase in PGC-1alpha 4. Myostatin protein levels are significantly lower in exercise 
groups compared to sedentary groups (p <0.05). Neither p-FOXO3aA nor FOXO3A 
demonstrates to be different among groups. However, pilot data using the ratio of p-
FOXO3A/total FOXO3A shows a trend of reduction in this ratio upon mechanical 
stimulation via resistance training. MuRF protein expression is significantly greater in CP 
group than that in sedentary group (p<0.05) and no differences exist among other groups. 
There is no significant difference in the expression of Atrogin across groups. However, 
atrogin levels tends to be higher following resistance training.  
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DISCUSSION 
     The primary findings of the present study was that myostatin levels, a negative 
regulator of muscle mass decreased upon resistance training. MuRF, known as one of the 
skeletal muscle specific E3 ubiquitin ligases, increased after resistance training when 
supplemented with carbohydrate and protein compared with sedentary control. Previous 
analysis conducted by Wang et al. (unpublished data) demonstrated that following 8 
weeks of resistance training, the gains in the maximal capacity were greater in the CP 
group compared with either PLA or WP groups (Figure 4). Although it was shown by 
Wang et al that resistance training did increase the FHL muscle mass, fiber CSA and 
muscle CSA when compared to sedentary control (Figure 3), which was indicative of 
muscle hypertrophy, there were no significant differences among training groups, 
suggesting that supplementations didn’t seem to further increase protein accretion. Total 
and myofibrillar protein concentration and content were then measured by Wang et al. 
and the content of myofibrillar protein was shown to be greater in the exercise groups 
than sedentary controls, demonstrating that resistance training induced myofibrillar 
protein accumulation. It was worth noting that myofibrillar protein content was greater 
for CP than for WP group and trended to be higher than PLA group, accounting for the 
higher increase in maximal capacity (Figure 2).  
     The net balance of protein synthesis and protein breakdown will dictate protein 
turnover and muscle mass. It was demonstrated by Wang et al. that the total protein 
content was elevated significantly in CP group and slightly elevated in WP and PLA 
groups compared with sedentary controls. Together with the CSA and mass data, it is 
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speculated that resistance training in the present study stimulated muscle protein 
synthesis. It was found by Wang et al. that IGF-1 protein expression increased only in the 
CP group compared with SED group (Figure1). In our study, we measured myostatin 
protein expression and found that to be down regulated significantly upon resistance 
training (Figure 5). IGF-1 acts as a stimulus for protein synthesis, functions through an 
autocrine/paracrine fashion. Upon mechanical stimulation, there’s a systemic elevation of 
IGF-1 as well as a higher utilization of circulating IGF-1 by the skeletal muscle 
(Goldspink, 2005), which allows a greater likelihood of IGF-1 to bind with IGF binding 
proteins, facilitating protein synthesis through PI3K-PKB-Akt-mTOR pathway. 
Myostatin, on the other hand, is thought to be negatively affecting protein synthesis by 
interacting with Akt/mTOR pathway. Kim et al. conducted a study investigating the 
impact of resistance loading on myostatin expression in different gender and age 
populations and found that resistance loading induced declines in myostatin mRNA 
transcripts in most of the populations(Kim, Cross, & Bamman, 2005). Another study 
conducted by Roth et al. also demonstrated that 9-week heavy resistance loading reduced 
myostatin mRNA levels ((Roth et al., 2003). However, in contrast to our findings and to 
those of Roth et al. and Kim et al., Willoughby reported increased levels of myostatin 
protein and mRNA after both 6 weeks and 12 weeks of resistance training (Willoughby, 
2004). The difference could be attributed to the timing of sample collection. Our study 
collected muscle samples 24h after the last training session while Willoughby collected 
muscle samples only 15 min after an exercise bout. A landmark study by Spiegelman’s 
group found an alternative splice variant of PGC-1alpha (PGC-alpha 4) to be involved in 
 32 
resistance training and functioned to regulate muscle mass (Ruas et al. 2012). In the 
present study, we showed a trend that PGC-1alpha 4 protein levels increased upon 
mechanical stimulation compared with SED and that the traditional PGC-1alpha 1 protein 
tended to decrease upon resistance training (Figure 5). Ruas et al. measured the mRNA 
levels of both total PGC-1alpha and the specific isoform 4 and found that resistance 
training protocol induced significant increase in both total PGC-1alpha and PGC-1alpha 
4 gene expressions and that there was a concomitant decrease in myostatin mRNA levels. 
The decrease of PGC-1alpha 1 protein levels could be explained by increased muscle 
mass, which resulted in a reduction of PGC-1alpha 1 protein concentration when the total 
amount of PGC-1alpha 1 protein didn’t change.  
                 Another interesting finding in the present study was that mediators 
involved in muscle protein breakdown seemed to be upregulated upon mechanical 
stimuli. It was found that no significant differences exist in either the phosphorylated 
form of FOXO3A or the total FOXO3A protein levels (Figure 6). However, the pilot data 
showing the ratio of phosphorylated FOXO3A over total FOXO3A did demonstrate a 
decrease of phosphorylated FOXO3A when normalized to the total protein level, 
suggesting that there might be an increase in muscle protein breakdown (Figure 6). 
FOXO3A is a transcriptional factor that can regulate the expressions of two muscle 
specific E3 ubiquitin ligases, atrogin 1 and MuRF1. Once phosphorylated, FOXO3A will 
translocate out of the nucleus to be inhibited from its activation on the expressions of the 
aforementioned proteolytic proteins. Therefore, with a decreased ratio of p-
FOXO3A/FOXO3A, one can expect that the expression of MuRF and atrogin would be 
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upregulated. Current study did show that MuRF was significantly elevated in the CP 
group when compared to SED and trended to be greater in the other two exercise groups 
than the SED group (Figure 6). Atrogin was also trending to be higher in the CP and WP 
group when compared to SED (Figure 6). Resistance exercise is believed to elevate both 
MPS and MPB without supplementation. In the current exercise protocol, rats were 
brought to failure in every training session, which might lead to a substantial increase in 
MPB due to robust elevation of cortisol. Studies have shown that generation of cortisol 
during high intensity resistance exercise can even lead to a negative net protein balance. 
It was thought that carbohydrate supplements could attenuate MPB by suppressing 
cortisol levels while upregulating insulin release. Wang et al. demonstrated that the 
corticosterone levels were significantly higher in the PLA and WP groups at the end of 
week 8 than SED group. However, CP group didn’t differ in corticosterone levels from 
SED group, suggesting that carbohydrate might indeed play a positive role in attenuating 
cortisol levels (unpublished data). The reason as to why MuRF protein expression was 
higher in CP group could be attributed to that rats in this particular group carried more 
weight till the end of 8 weeks and might have stimulated MPB more than the other 
groups. 
    In summary, consistent with the previous studies using the same exercise 
protocol (Hornberger and Farrar, 2004), there was an increase in mass of the FHL muscle 
as well as an increase in myofirillar protein content, suggesting protein accumulation 
over the 8 weeks of training. Elevation of IGF-1 and reduction of myostatin suggests that 
protein accretion may be achieved through Akt-mTOR signaling pathway, which serves 
 34 
as a critical signaling pathway regulating protein synthesis and needs to be further 
investigated. Increase in MuRF and other related proteolytic markers indicate that there 
could be an upregulation of protein breakdown. However, since there was a positive net 
protein balance suggested by muscle hypertrophy, the rate of muscle protein synthesis 
must have surpassed the rate of muscle protein breakdown. It would be of great 
significance to obtain direct evidence of muscle protein synthesis and related signaling 
substrates to further understand the mechanisms in terms of how resistance training and 
different supplements dictate muscle hypertrophy. 
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FIGURES 
Figure 1: IGF-1 protein expression. Taken from Wang et al. (unpublished).    
                     IGF-1 protein expression as a percentage of a standard sample obtained     
from an insulin-stimulated tissue. Data are presented as mean ± SEM (n=7-8 per group). 
*, p ≤ 0.05 vs SED. 
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Figure 2: Total and myofibrillar proteins. Taken from Wang et al. (unpublished).  
A) Total protein concentration. B) Total protein content per muscle. C) Myofibrillar 
protein concentration. D) Myofibrillar protein content per muscle. Data are presented as 
mean ± SEM (n=7-8 per group). *, p ≤ 0.05 vs SED. §, p ≤ 0.05 vs WP. 
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Figure 3: Cross sectional area. Taken from Wang et al. (unpublished).  
A) Fiber cross sectional area. B) FHL muscle cross sectional area. C) Cross section of 
FHL muscle in untrained rats (20x objective lens). Data are presented as mean ± SEM 
(n=7-8 per group). *, p ≤ 0.05 vs SED. 
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Figure 4: Maximal carrying load per training session over 8 weeks.  
Taken from Wang et al. (unpublished). Data are presented as mean ± SEM (n=7-8 per 
group). ƒ, significant treatment effect in CP vs PLA and WP. #, p ≤ 0.05 vs PLA, §, p ≤ 
0.05 vs WP. 
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A B  
C  
Figure 5: Myostatin protein expression decreases after resistance training.  
                     
A) PGC-1alpha isoform 1 protein expression expressed as a percentage of sedentary 
control. B) PGC-1alpha isoform 4 protein expression expressed as a percentage of 
sedentary control. C) Myostatin protein expression expressed as a percentage of 
sedentary control. Data are presented as mean ± SEM (n=7-8 per group). *, p ≤ 0.05 vs 
SED. 
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A B  
C D  
Figure 6: MuRF protein expression increases after resistance training when 
supplemented with CHO+Whey.   
 41 
E  
Figure 6: MuRF protein expression increases after resistance training when supplemented 
with CHO+Whey.   
A) MuRF protein expression expressed as a percentage of sedentary control. B) Atrogin 
protein expression expressed as a percentage of sedentary control. C) p-FOXO3A protein 
expression expressed as a percentage of sedentary control. D) FOXO3A protein 
expression expressed as a percentage of sedentary control. E) Pilot data for p-
FOXO3A/FOXO3A ratio. Data are presented as mean ± SEM (n=7-8 per group). *, p ≤ 
0.05 vs SED. 
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Appendices 
APPENDIX A: WESTERN BLOT 
Solutions 
1.5M Tris, pH8.8 (500ml) 
Add 90.82g Trisbase to 400ml ddH2O stirring on a magnetic plate and bring to 500ml 
volume with ddH2O. Adjust pH to 8.8 with 12N and 1N HCl. Store it at 4°C. 
1.0M Tris, pH 6.8 (500ml) 
Add 60.57g Trisbase to 400ml ddH2O stirring on a magnetic plate and bring to 500ml 
volume with ddH2O. Adjust pH to 6.8 with 12N and 1N HCl. Store it at 4°C. 
20% SDS (100ml) 
Add 20g SDS to 80ml ddH2O stirring on a magnetic plate and bring to 100ml volume 
with ddH2O. Filter this solution through Whatman #1 filter paper. 
10% APS (1ml) 
Add 0.1g APS to 1.5ml test tube with 1ml ddH2O and vortex until dissolve. Make fresh 
daily. 
10 x Running Buffer (2L) 
Reagent Amount (g) 
Trisbase 60.56 
Glycine 288.4 
SDS 20g 
Add the reagents into 1.5L ddH2O stirring on a magnetic plate and bring to the volume 
with ddH2O 
10x TTBS (2L, pH7.4) 
Reagent Amount 
TrisBase 24.2 g 
NaCl 175.36 g 
Tween 20 12 ml 
Add the reagents into 1.5L ddH2O stirring on magnetic plate and bring to the volume 
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Anode II solution 
 
 
 
 
 
 
 
 
 
 
 
 
 Component Reagent and Amount  
    
  25mM Tris 
25 mL of 1 M Tris 
Stock 
    
  0.05% SDS 2.5 mL of 20% SDS 
    
  10% methanol 100 mL 
    
  
10mM  
β-mercaptoethanol 0.78 mL 
     
 * Bring to 1 L    
Cathode solution 
 (Bring to 1L)    
    
 Component  
Reagent and 
Amount 
    
 25mM Tris  
25 mL of 1 M Tris 
Stock 
   
 
40 mM α-amino hexanoic 
acid 5.248 g 
    
 0.05% SDS  2.5 mL of 20% SDS 
    
 10% methanol  100 mL 
    
 
10mM  
β-mercaptoethanol  0.78 mL 
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Procedure 
12.5% Separating Gel 15% Separating Gel 18% Separating Gel 
3.13 mL 40% Acrylamide 3.76 mL 40% Acrylamide 4.51 mL 40% Acrylamide 
0.35 mL 2% Bis 0.41 mL 2% Bis 0.49 mL 2% Bis 
2.50 mL 1.5 M Tris pH 6.8 2.50 mL 1.5M Tris pH 6.8 2.50 mL 1.5M Tris pH 6.8 
50 uL 20% SDS 50 uL 20% SDS 50 uL 20% SDS 
3.93 mL dH2O 3.23 mL dH2O 2.39 mL dH2O 
32.5 uL 10% APS 38.94 uL 10% APS 46.71 uL 10% APS 
6.25 uL TEMED 7.50 uL TEMED 8.99 uL TEMED 
 
 
1.Add all reagents above into 50ml test tube. Then mix them and fill ¾ full caster with a 
glass pipette. Overlay with 300ul butanol. Allow 1h for gel to polymerize. 
2.After gel polymerization, pour off butanol from the resolving gel and rinse between 
casting plates with ddH2O and dry it with KimWipes. 
3.Preparing stacking gel solution (for 2 gels) 
5% Stacking Gel 
1.25 mL 40% Acrylamide 
0.65 mL 2% Bis 
1 mL 1.5 M Tris pH 6.8 
50.0 Ul 20% SDS 
6.99 mL dH2O 
50 uL 10% APS 
10 uL TEMED 
 
4.Add al reagents above into 15ml test tube. Then mix them and fill the caster with 
stacking gel solution then put combs into place. Allow 45 min for stacking gel to 
polymerize. 
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5.Preparing samples 
a. Take the samples our of -80°C and thaw them on ice 
b. Dilute samples 1:3 with sample buffer in labeled microcentrifuge tubes. 
c. Vortex and place in boiling water (~90-95°C) for 8min 
6.Preparing 1 x Running buffer 
Add 100ml 10x Running buffer into 900ml ddH2O stirring on a magnetic plate. 
7.After stacking gel has polymerized, carefully remove the combs and assemble gel 
apparatus. Fill inner chamber and out chamber with 1 x running buffer. 
8.Turn on power supply and set to constant current (50 mA for every module connected), 
200 V, and 200 W. Run for appropriate time (i.e. when desired separation is achieved). 
9.After running is completed, proceed to membrane transfer. 
1.) Pour an appropriate amount of Anode I solution into a weigh boat. 
2.) Remove gel from electrophoresis module and carefully remove short plate. Slowly cut 
gel at desired molecular weights. Notch the top corner of lane 1 and place in Anode I 
solution filled weigh boat. 
3.) Cut a piece of PDVF membrane the size of the gel just prepared. Mark the upper 
right-hand corner with a pencil. Place this into pure methanol, then move to another 
weigh boat containing Anode I solution. Allow to equilibrate for at least 5 minutes. 
4.) Cut 2 pieces of extra-thick blotting paper that corresponds in size to the membrane (2 
pieces for every membrane). Soak 1 of these in Anode II solution. 
5.) Open transfer cell and gently place Anode II solution-soaked blotting paper to 
electrode. Roll over with test tube to remove all air bubbles. 
 
6.) Remove membrane from Anode I solution and place on top of blotting paper. Roll test 
tube over. 
7.) Gently place soaked gel over membrane and make sure notched corner lines up with 
marked membrane corner. Check to see if any air bubbles. 
8.) Soak other piece of blotting paper in Cathode solution. Remove and place over gel. 
Roll over with test tube. 
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9.) Replace transfer cell cover. Turn ON power supply and set to 300 mA constant 
current, 25 V, and 200 W. Time of transfer will depend on size and abundance of protein 
of interest. 
10. After transfer, proceed to immunoblot: 
1.) Prepare 25 mL of 5% milk in TBST for every membrane being transferred. Pour milk 
into plastic shaking dish. 
 
2.) Remove membrane from transfer cell and place in milk. Rotate at room temperature 
for at least 1 hour. 
3.) Depending on primary antibody to be used, prepare 5 mL of either 1% milk-TBST 
(Santa Cruz antibodies) or 5% BSA-TBST (Cell Signaling antibodies). Transfer to a 
properly labeled 15 mL conical tube. Add appropriate amount of primary antibody to 
achieve desired dilution (usually 1:1000 works). 
4.) Pour milk out of shaker and add a small amount of TBST to rinse milk off of 
membrane. Using gloves and forceps, remove membrane from shaker and curve to fit 
into the tube containing the prepared primary antibody solution. Make sure protein 
covered side is facing inward (i.e. is exposed to the primary antibody). Place in 4 ºC 
rotator overnight. 
 
5.) Add ~15 mL of TBST to a plastic shaker, and remove membrane from 15 mL conical 
tube to place in shaker. Rotate at room temperature for 15 minutes. Perform 3 washes 
total. Return primary antibody solution to 4 ºC. 
 
6.) Prepare 10 mL of either 1% milk-TBST (Santa Cruz antibodies) or 5% milk-TBST 
(Cell Signaling antibodies). Add appropriate amount of correct secondary antibody to 
achieve a 1:2000 dilution (may need to adjust, depending on antibody used). Rotate at 
room temperature for at least 1 hour (2 hours for better results). 
7.) Dump out secondary antibody solution, rinse with TBST, and perform 5 5-minute 
washes with TBST. 
 
 
Membrane stripping and re-probing 
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1. Wash membrane in the ddH2O for 5min. 
2. Add membrane to 0.2N NaOH for 5-7 min. 
3. Wash membrane in the ddH2O for 5 min, followed by another 5 min wash using TBST. 
4.  After washing, membrane can be re-blocked and then re-probed with another antibody. 
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APPENDIX B: RAW DATA 
MuRF 
cp	   wp	   pla	   sed	  
1.120006955	   0.734638527	   0.831860697	   1	  
2.00900583	   1.631986775	   1.696645518	   1	  
1.99446746	   2.011636438	   1.568391694	   1	  
2.560282546	   1.306386054	   1.349275333	   1	  
1.219361056	   0.778795959	   1.455988754	   1	  
0.976959114	   0.938050456	   0.972843108	   1	  
1.686947021	   0.717075941	   1.076927549	   1	  
1.338672815	   1.07846249	   	  	   1	  
	  
	   	   	   	  
Atrogin 
cp	   wp	   pla	   sed	  
0.707878828	   0.769840104	   0.76297374	   1	  
0.686343014	   1.033614101	   	  	   1	  
0.721139902	   1.917511866	   1.807912917	   1	  
3.231235849	   1.403049577	   0.99352492	   1	  
1.331263923	   0.966618679	   0.663594351	   1	  
5.033127936	   2.745865683	   0.782227654	   1	  
2.357105538	   2.240965077	   0.946443942	   1	  
	  
	   	   	   	  
Myostatin 
cp	   wp	   pla	   sed	  
0.826002747	   0.812038277	   0.807463289	   1	  
0.305787216	   0.38249576	   0.240144133	   1	  
0.351463893	   0.283639069	   0.597576414	   1	  
0.576286718	   0.792040773	   0.701895541	   1	  
0.574163761	   0.866086592	   0.515230201	   1	  
FOXO3A	  
	  
cp	   wp	   pla	   sed	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1.396256191	   1.367060908	   0.663559403	   1	  
0.898109821	   1.092107592	   1.44112084	   1	  
0.980289524	   1.015689274	   0.545670085	   1	  
0.687119716	   0.653182415	   1.482842456	   1	  
0.613551131	   0.584628493	   0.917372931	   1	  
0.925325585	   0.578545775	   0.613360481	   1	  
0.696030779	   0.811881064	   0.955043387	   1	  
2.175139381	   1.465184545	   0.455965923	   1	  
0.97580735	   1.786927151	   0.548359338	   1	  
1.499464916	   0.575533399	   1.274771299	   1	  
2.604099805	   1.59599372	   1.539370429	   1	  
 
p-FOXO3A 
cp	   wp	   pla	   sed	  
0.833131558	   0.123140885	   1.226787976	   1	  
0.475871932	   0.452177635	   0.180104413	   1	  
2.207873891	   1.369117004	   1.102878382	   1	  
1.027913085	   1.694953831	   0.393556059	   1	  
 
p-FOXO3A/FOXO3A 
cp	   wp	   pla	   sed	  
0.383024447	   0.151673552	   0.717697378	   1	  
0.317361164	   0.253047605	   0.188582441	   1	  
 
PGC-1alpha 4 
cp	   wp	   pla	   sed	  
1.139567702	   1.274946274	   1.355793673	   1	  
0.648871712	   1.082552889	   0.372875381	   1	  
1.829451727	   2.002934512	   1.870807041	   1	  
3.084392518	   1.966231161	   1.458852521	   1	  
 50 
 
PGC-1alpha 1 
cp	   wp	   pla	   sed	  
0.597270562	   0.55663121	   0.648019729	   1	  
0.456591331	   0.185356953	   0.385304465	   1	  
0.919510598	   0.547114965	   0.314651877	   1	  
0.695572024	   0.655357654	   1.203460069	   1	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